Rhenman & Partners Asset Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $7.62M | Buy |
|
|||||
|
2023
Q2 | $5.06M | Sell |
|
|||||
|
2023
Q1 | $7.89M | Sell |
|
|||||
|
2022
Q4 | $13.6M | Buy |
|
|||||
|
2022
Q3 | $13.3M | Buy |
|
|||||
|
2022
Q2 | $12.8M | Buy |
|
|||||
|
2022
Q1 | $12.3M | Sell |
|
|||||
|
2021
Q4 | $22.2M | Hold |
|
|||||
|
2021
Q3 | $26.5M | Sell |
|
|||||
|
2021
Q2 | $26.7M | Buy |
|
|||||
|
2021
Q1 | $25.7M | Buy |
|
|||||
|
2020
Q4 | $22M | Sell |
|
|||||
|
2020
Q3 | $19M | Buy |
|
|||||
|
2020
Q2 | $11.4M | Sell |
|
|||||
|
2020
Q1 | $9.99M | Buy |
|
|||||
|
2019
Q4 | $16.1M | Buy |
|
|||||
|
2019
Q3 | $7.79M | Sell |
|
|||||
|
2019
Q2 | $18.7M | Buy |
|
|||||
|
2019
Q1 | $9.32M | Buy |
|
|||||
|
2018
Q4 | $3.61M | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $183K | Hold |
|
|||||
|
2017
Q1 | $260K | Hold |
|
|||||
|
2016
Q4 | $238K | Hold |
|
|||||
|
2016
Q3 | $331K | Hold |
|
|||||
|
2016
Q2 | $273K | Hold |
|
|||||
|
2016
Q1 | $1.07M | Hold |
|
|||||
|
2015
Q4 | $1.58M | Hold |
|
|||||
|
2015
Q3 | $1.72M | Hold |
|
|||||
|
2015
Q2 | $1.57M | Buy |
|
|||||
|
2015
Q1 | $1.33M | Buy |
|